Economic models in type 2 diabetes

Current Medical Research and Opinion
Y YiK Burslem

Abstract

To identify and critically appraise cost-effectiveness models developed to evaluate type 2 diabetes (T2D) treatments and to assess which types of treatment effects they capture. A systematic search was performed in MEDLINE, EMBASE, Centre for Reviews and Dissemination databases at the University of York, and Health Economic Evaluation Database for the period to September 2008. The websites of Health Technology Assessment (HTA) bodies in different countries were also screened for relevant models. For each of the identified original models, details of the structure, data in- and outputs were extracted and the overall quality of the model in terms of the combination of structure, assumptions and data inputs were appraised using published criteria. Seventy-eight articles and 41 HTAs reporting relevant economic evaluations were identified. There were ten models with multiple publications, and a further ten models with one associated publication. The critical review demonstrated that most had the same fundamental structure, used similar micro-simulation techniques and were based on the same key data sources. However, the process for identification of relevant data and their synthesis, and the selection of outcomes lacked transparency...Continue Reading

References

Jan 1, 1984·American Journal of Epidemiology·R KleinP S Voss
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
May 1, 1997·Diabetes Care·R C EastmanM Harris
Jan 1, 1999·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·R R Brown
Oct 12, 2000·International Journal of Technology Assessment in Health Care·J NixonJ Kleijnen
Nov 18, 2000·Diabetes Research and Clinical Practice·J B BrownM Aickin
Nov 18, 2000·Diabetes Research and Clinical Practice·A J PalmerH Wenzel
May 31, 2002·PharmacoEconomics·Douglas CoyleBernie J O'Brien
Oct 28, 2003·Diabetes Care·David M Eddy, Leonard Schlessinger
Aug 25, 2004·Current Medical Research and Opinion·Andrew J PalmerGiatgen A Spinas
Nov 5, 2004·Health Technology Assessment : HTA·E WarrenC Beverley
Mar 2, 2005·International Journal of Technology Assessment in Health Care·Cynthia P IglesiasUNKNOWN NEVALAT Project Group
Apr 19, 2005·Diabetologia·P M ClarkeUNKNOWN UKPDS 72 United Kingdom Prospective Diabetes Study
Aug 17, 2005·Annals of Internal Medicine·David M EddyRichard Kahn
Feb 9, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·I W Campbell
May 13, 2006·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·David Eddy
Jul 1, 2006·Biomedical Engineering Online·A Boutayeb, A Chetouani

❮ Previous
Next ❯

Citations

May 28, 2014·PharmacoEconomics·Véronique RaimondLise Rochaix
Nov 5, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Florian Kirsch
Jul 16, 2015·Expert Review of Pharmacoeconomics & Outcomes Research·Gerardus Wj FrederixAnke M Hövels
Oct 17, 2015·Current Medical Research and Opinion·M Charokopou
Jan 23, 2016·PharmacoEconomics·Martin HenrikssonMichael Willis
Nov 22, 2011·Expert Review of Pharmacoeconomics & Outcomes Research·Christian BeckerReiner Leidl
Mar 22, 2015·Journal of Diabetes and Its Complications·Yeganeh Manon KhazraiPaolo Pozzilli
Nov 12, 2013·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Jung Min OhSang Kyum Kim
Aug 30, 2016·Expert Review of Pharmacoeconomics & Outcomes Research·Bjoern SchwanderSilvia Evers
Nov 7, 2015·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Manel Mata-CasesBonaventura Bolíbar
Feb 19, 2016·Diabetes/metabolism Research and Reviews·Balázs NagyZoltán Vokó
Aug 23, 2018·Journal of Comparative Effectiveness Research·Bin WuHaixiang Wu
Jun 4, 2021·Acta Diabetologica·Jiayu LiLimin Tian

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.